Finpecia en es it fr

Finpecia Brand names, Finpecia Analogs

Finpecia Brand Names Mixture

  • No information avaliable

Finpecia Chemical_Formula


Finpecia RX_link

Finpecia fda sheet

Finpecia FDA

Finpecia msds (material safety sheet)

Finpecia Synthesis Reference

No information avaliable

Finpecia Molecular Weight

372.544 g/mol

Finpecia Melting Point

252-254 oC

Finpecia H2O Solubility

11.7 mg/L

Finpecia State


Finpecia LogP


Finpecia Dosage Forms


Finpecia Indication

For the treatment of symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate to: Improve symptoms, reduce the risk of acute urinary retention, reduce the risk of the need for surgery including transurethral resection of the prostat.

Finpecia Pharmacology

Finasteride is indicated for the treatment of male pattern hair loss (androgenetic alopecia) in men only. Finasteride is a competitive and specific inhibitor of Type II 5a-reductase, an intracellular enzyme that converts the androgen testosterone into DHT. Two distinct isozymes are found in mice, rats, monkeys, and humans: Type I and II. Each of these isozymes is differentially expressed in tissues and developmental stages. In humans, Type I 5a-reductase is predominant in the sebaceous glands of most regions of skin, including scalp, and liver. Type I 5a-reductase is responsible for approximately one-third of circulating DHT. The Type II 5a-reductase isozyme is primarily found in prostate, seminal vesicles, epididymides, and hair follicles as well as liver, and is responsible for two-thirds of circulating DHT.

Finpecia Absorption

No information avaliable

Finpecia side effects and Toxicity

No information avaliable

Finpecia Patient Information

No information avaliable

Finpecia Organisms Affected

Humans and other mammals